Ameriprise Financial Inc Castle Biosciences Inc Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 295,327 shares of CSTL stock, worth $6.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

295,327

Previous 279,727 5.58%

Holding current value

$6.43 Million

Previous $6.04 Million 8.37%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$18.06 - $25.3 $281,736 - $394,680	15,600 Added 5.58%	295,327 $6.54 Million
Q4 2023 Feb 14, 2024	BUY	$12.19 - $22.43 $167,332 - $307,896	13,727 Added 5.16%	279,727 $6.04 Million
Q3 2023 Nov 14, 2023	SELL	$13.28 - $20.3 $689,949 - $1.05 Million	-51,954 Reduced 16.34%	266,000 $4.49 Million
Q2 2023 Aug 14, 2023	BUY	$11.66 - $26.0 $2.37 Million - $5.28 Million	203,045 Added 176.7%	317,954 $4.36 Million
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $71,454 - $104,558	3,670 Added 3.3%	114,909 $2.61 Million

Q4 2022 Feb 14, 2023	SELL	$18.08 - $30.0 $384,760 - $638,430	-21,281 Reduced 16.06%	111,239 $2.62 Million
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $622,041 - $948,398	-27,634 Reduced 17.25%	132,520 $3.46 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $585,376 - $1.68 Million	36,586 Added 29.61%	160,154 $3.52 Million
Q1 2022 May 16, 2022	BUY	$33.17 - $46.98 $472,572 - $669,324	14,247 Added 13.03%	123,568 $5.55 Million
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $665,348 - $1.15 Million	17,034 Added 18.46%	109,321 $4.69 Million
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $60,430 - $77,988	-1,005 Reduced 1.08%	92,287 $6.14 Million
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $789,103 - $1.21 Million	-15,760 Reduced 14.45%	93,292 $6.84 Million
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $1.47 Million - $2.43 Million	-24,950 Reduced 18.62%	109,052 $7.47 Million
Q4 2020 Feb 12, 2021	SELL	$43.6 - $73.05 $519,450 - $870,317	-11,914 Reduced 8.16%	134,002 $9 Million
Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $1.81 Million - $2.44 Million	46,923 Added 47.4%	145,916 $7.51 Million
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $1.66 Million - $2.62 Million	60,993 Added 160.51%	98,993 $3.73 Million
Q1 2020 May 15, 2020	BUY	$23.08 - $35.53 $877,039 - $1.35 Million	38,000 New	38,000 $1.13 Million

Others Institutions Holding CSTL

# of Institutions

162

Shares Held

25.3M

Call Options Held

82.2K

Put Options Held

150K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $572M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Castle Biosciences Inc Transaction History